Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1135951/000157587218000214/drr0078_6k.htm
January 2023
January 2023
January 2023
January 2023
January 2023
January 2023
January 2023
January 2023
December 2022
December 2022
Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1135951/000157587218000214/drr0078_6k.htm
Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Dr Reddys Laboratories Ltd provided additional information to their SEC Filing as exhibits
Ticker: RDY
CIK: 1135951
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001575872-18-000214
Submitted to the SEC: Thu Oct 25 2018 12:37:28 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Thursday, October 25, 2018
Industry: Pharmaceutical Preparations